• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浅表性膀胱癌

Superficial bladder cancer.

作者信息

Hall R R

机构信息

Freeman Hospital, High Heaton, Newcastle upon Tyne.

出版信息

BMJ. 1994 Apr 2;308(6933):910-3. doi: 10.1136/bmj.308.6933.910.

DOI:10.1136/bmj.308.6933.910
PMID:8173377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2539828/
Abstract

Bladder cancer is almost certainly a product of the industrial revolution and the cigarette smoking that has accompanied it. Exposure to a chemical bladder carcinogen such as beta naphthylamine, benzidine, or 4-diphenylaniline can be proved in only a small proportion of patients and only a handful obtain industrial diseases benefit after developing "Prescribed Industrial Disease C23." None the less, the continued use of known carcinogenic substances in British industry for many years after their identification, the wide range of industries with a known or suspected increased risk of bladder cancer, and our ignorance of the carcinogenic potential of many materials used in current manufacturing should be a cause for continuing concern.

摘要

膀胱癌几乎可以肯定是工业革命及其伴随的吸烟的产物。仅在一小部分患者中能够证明接触过化学性膀胱致癌物,如β-萘胺、联苯胺或4-二苯胺,并且只有少数人在患上“规定的职业病C23”后获得了职业病福利。尽管如此,在已知致癌物质被识别后的许多年里,它们仍在英国工业中持续使用,众多已知或疑似膀胱癌风险增加的行业,以及我们对当前制造业中使用的许多材料的致癌潜力的无知,都应持续引发关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df1/2539828/2532b177a773/bmj00434-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df1/2539828/2532b177a773/bmj00434-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df1/2539828/2532b177a773/bmj00434-0050-a.jpg

相似文献

1
Superficial bladder cancer.浅表性膀胱癌
BMJ. 1994 Apr 2;308(6933):910-3. doi: 10.1136/bmj.308.6933.910.
2
Management of superficial transitional cell carcinoma of the bladder.膀胱浅表性移行细胞癌的管理
Semin Urol. 1993 Nov;11(4):193-204.
3
Intravesical therapy for superficial bladder cancer.浅表性膀胱癌的膀胱内灌注治疗
Semin Urol Oncol. 2000 Nov;18(4):280-8.
4
[Treatment and follow-up of superficial bladder cancer].[浅表性膀胱癌的治疗与随访]
Duodecim. 2002;118(9):903-9.
5
Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
Scand J Urol Nephrol Suppl. 1991;138:167-77.
6
Intravesical therapy of bladder cancer: an immunotherapy success story.膀胱癌的膀胱内治疗:免疫治疗的成功案例。
Int J Urol. 1996 Sep;3(5):329-33. doi: 10.1111/j.1442-2042.1996.tb00548.x.
7
Superficial bladder disease: case studies and therapeutic advances.
Urology. 1992 Dec;40(6 Suppl):11-22.
8
BCG in carcinoma in situ and superficial bladder tumors.
Prog Clin Biol Res. 1988;269:497-510.
9
BCG for bladder cancer.
Med Lett Drugs Ther. 1991 Apr 5;33(841):29-30.
10
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.用于浅表性膀胱癌的卡介苗-荷兰国家公共卫生与环境研究所膀胱内免疫预防
Prog Clin Biol Res. 1988;269:511-24.

本文引用的文献

1
Thiotepa in the treatment of tumours of the bladder.
Lancet. 1961 Sep 16;2(7203):615-8. doi: 10.1016/s0140-6736(61)90304-x.
2
Smoking and death rates: report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause.吸烟与死亡率:对187,783名男性进行44个月随访的报告。2. 按病因划分的死亡率
J Am Med Assoc. 1958 Mar 15;166(11):1294-308. doi: 10.1001/jama.1958.02990110030007.
3
A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder.一项欧洲癌症研究与治疗组织泌尿生殖系统肿瘤组的前瞻性随机试验,比较经尿道切除术联合单次膀胱内灌注表柔比星或水用于单发Ta、T1期膀胱乳头状癌的单阶段治疗。
J Urol. 1993 Apr;149(4):749-52. doi: 10.1016/s0022-5347(17)36198-0.
4
Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.膀胱癌中p53突变的独特模式:与烟草使用的关系。
Cancer Res. 1993 Mar 1;53(5):1162-6.
5
An international study of smoking and bladder cancer.一项关于吸烟与膀胱癌的国际研究。
J Urol. 1984 Apr;131(4):650-4. doi: 10.1016/s0022-5347(17)50559-5.
6
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
J Clin Oncol. 1988 Sep;6(9):1450-5. doi: 10.1200/JCO.1988.6.9.1450.
7
Should pT1 transitional cell cancers of the bladder still be classified as superficial?
Br J Urol. 1988 Sep;62(3):235-9. doi: 10.1111/j.1464-410x.1988.tb04325.x.
8
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).膀胱内注射丝裂霉素C对新诊断的浅表性膀胱癌复发的影响:医学研究委员会浅表性膀胱癌小组(泌尿外科癌症工作组)的中期报告。
Br Med J (Clin Res Ed). 1988 Jun 25;296(6639):1759-61. doi: 10.1136/bmj.296.6639.1759.
9
The pT1 G3 bladder tumour.pT1 G3期膀胱肿瘤。
Br J Urol. 1989 Aug;64(2):109-16. doi: 10.1111/j.1464-410x.1989.tb05967.x.
10
Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).浅表性膀胱癌治疗中复发的预后因素及随访策略:英国医学研究理事会浅表性膀胱癌小组(泌尿外科癌症工作组)报告
J Urol. 1989 Aug;142(2 Pt 1):284-8. doi: 10.1016/s0022-5347(17)38731-1.